836 results on '"Cohen, R. D."'
Search Results
2. P848 Risankizumab Effectiveness in Ustekinumab-naïve and Ustekinumab-experienced Patients with Crohn’s Disease- Real-world Data from a Large Tertiary Center
3. P465 Upadacitinib is effective and safe for the treatment of ulcerative colitis and Crohn’s disease: 1-year prospective real-world experience
4. HST UV and Keck HIRES Spectra of BAL Quasars
5. Discovery of a 2 Kpc Binary Quasar
6. LBQS 0103-2753: A 0.3 Arcsec Binary Quasar
7. High-Velocity Narrow-Line Absorbers in QSOs
8. Ionization and Abundances in Intrinsic QSO Absorption-Line Systems
9. Lick Slit Spectra of Thirty-Eight Objective Prism QSO Candidates and Low Metallicity Halo Stars
10. P800 Upadacitinib is effective and safe for Crohn’s Disease: prospective real-world experience
11. P724 Upadacitinib is Effective and Safe in Tofacitinib-Experienced Patients with Ulcerative Colitis: A Prospective Real-World Experience
12. P580 Upadacitinib is effective and safe for Ulcerative Colitis: prospective real-world experience
13. DOP045 Combination therapy with anti-TNF and immunosuppressive therapies is the most effective medication to prevent and treat endoscopic postoperative recurrence in patients with Crohn’s disease
14. Clinical Implications of the Pathophysiology of Lactic Acidosis: The Role of Defects in Lactate Disposal
15. Bernard Joseph Peck
16. Accuracy of Doppler Ultrasound in Diagnosing Pregnancy in Bighorn Sheep
17. P260 An analysis of non-melanoma skin cancer rates in the tofacitinib Ulcerative Colitis clinical programme
18. Disturbances of acid–base homeostasis
19. The Techniques and Uses of Intracellular pH Measurements
20. Systematic review: the costs of ulcerative colitis in Western countries
21. Metabolic changes during the treatment of myxoedema
22. Review article: increasing the dose of oral mesalazine therapy for active ulcerative colitis does not improve remission rates
23. Pulmonary actinomycosis complicating infliximab therapy for Crohn’s disease
24. Haemodynamic and metabolic effects in diabetic ketoacidosis in rats of treatment with sodium bicarbonate or a mixture of sodium bicarbonate and sodium carbonate
25. Ketone bodies promote a rapid rise in glutamate efflux from the isolated perfused rat liver without altering the rate of glutamine production
26. Carrier-mediated lactate entry into isolated hepatocytes from fed and starved rats: Zonal distribution and temperature dependence
27. Fatal flaw in the fetal argument
28. evolutionary advances in the delivery of aminosalicylates for the treatment of ulcerative colitis
29. Intentional infliximab use during pregnancy for induction or maintenance of remission in Crohnʼs disease
30. Hormonal modulation of hepatic plasma membrane lactate transport in cultured rat hepatocytes
31. The quality of life in patients with Crohnʼs disease
32. Efficacy of parenteral methotrexate in refractory Crohn’s disease
33. HST, IUE and ROSAT Observations of High Z QSOs
34. Imperial Cancer Research Fund and The Lancet
35. Steps toward determination of the size and structure of the broad-line region in active galatic nuclei. 8: An intensive HST, IUE, and ground-based study of NGC 5548
36. Faecal calprotectin is highly effective to detect endoscopic ulcerations in Crohn's disease regardless of disease location
37. Histological activity in Crohn's disease: Relationship with clinical indices, endoscopic activity and faecal calprotectin
38. Natural history of Crohn's disease postoperative recurrence in a referral centre in the era of biologics and therapeutic intensification based on early endoscopic findings
39. Faecal calprotectin is a very reliable tool to predict and monitor the risk of relapse after therapeutic de-escalation in patients with inflammatory bowel diseases
40. Combination therapy with anti-TNF and immunosuppressive therapies is the most effective medication to prevent and treat endoscopic postoperative recurrence in patients with Crohn's disease
41. Steps toward determination of the size and structure of the broad-line region in active nuclei. 7: Variability of the optical spectrum of NGC 5548 over years
42. Steps toward determination of the size and structure of the broad-line region in active galactic nuclei. 8: An intensive HST, IUE, and ground-based study of NGC 5548
43. Performance of the FOS Detectors in a Variable External Magnetic Field
44. On-Orbit Sky Background Measurements with the FOS
45. Unsteady heat transfer from a sphere at low Reynolds and Strouhal numbers
46. Comment on: Nyirenda MJ, Dean S, Lyons V, Chapman KE, Seckl JR (2006) Prenatal programming of hepatocyte nuclear factor 4a in the rat: a key mechanism in the ‘foetal origins of hyperglycaemia’? Diabetologia 49: 1412–1420, and on: McCurdy CE, Friedman JE (2006) Early foetal programming of hepatic gluconeogenesis: glucocorticoids strike back. Diabetologia 49:1138–1141
47. DOP41 Efficacy and safety of open-label treatment with tofacitinib 10 mg twice daily in patients with ulcerative colitis with clinical response, but not remission, after 52 weeks of maintenance therapy: data from the OCTAVE studies
48. P358 Ustekinumab is effective for the treatment of chronic antibiotic-refractory pouchitis
49. P500 Post-marketing safety experience of vedolizumab in patients receiving concomitant treatment with other biologics
50. Unwarranted Assumptions in Our 'Innovative' Science Curricula, Part 1
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.